Pune (Maharashtra) [India], January 22 (ANI): The supply of COVID-19 vaccines has not been affected due to the recent fire that broke out at the Serum Institute of India's (SII) facility in Pune, confirmed the company's CEO Adar Poonawalla on Friday.
New Delhi [India], January 16 (ANI): Serum Institute of India (SII) CEO Adar Poonawalla on Saturday wished Prime Minister Narendra Modi success in launching the vaccination rollout in the country.
New Delhi [India], November 28 (ANI): After Prime Minister Narendra Modi visited the company's pandemic level facility in Pune, Serum Institute of India's (SII), Chief Executive Officer (CEO) Adar Poonawalla on Saturday said that indications suggest that the central government may purchase 3
New Delhi [India], November 23 (ANI): Serum Institute of India (SII), CEO, Adar Poonawalla on Monday said that he is delighted to hear that Covidshield, soon to be widely available COVID-19 vaccine, will offer protection up to 90 per cent in one dosage regime and 62 per cent in another.
New Delhi [India], Feb 12 (ANI): Svasti Microfinance Private Limited (Svasti) has raised a total of Rs. 34 Crores capital from Nordic Microfinance Initiative (NMI), Serum Institute of India CEO Adar Poonawalla, and other investors.